Pages

Saturday, September 25, 2010

Breast Cancer Test Predicts Chemo Benefit & Recurrence Risk

See how Genomic Health is turning the promise of genomics...into the practice of medicine with Oncotype DX®, a test that is individualizing treatment for tens of thousands of breast cancer patients. About the Oncotype DX test: Oncotype DX is a diagnostic test that examines the genomic profile of a breast cancer tumor to determine whether a woman will benefit from chemotherapy. To learn more, visit: www.mytreatmentdecision.com

Visit : Telephoto lens online Baby strollers

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.